Casey M. Kalman, MPH

Centers for Disease Control and Prevention
Washington, District of Columbia, United States

Disclosure information not submitted.

Presentation(s):

• 561 - Reduction of RSV-associated hospitalization rates during the 2024-2025 RSV Season among infants <6 months of age.

  Wednesday, October 22, 2025
  10:42 AM - 10:54 AM US ET

• 562 - Maternal RSV Vaccine and Nirsevimab Effectiveness against Medically Attended RSV Disease in Infants, United States

  Wednesday, October 22, 2025
  10:54 AM - 11:06 AM US ET